Generic drug user fee amendments : accelerating patient access to generic drugs : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Fourteenth Congress, second session ... January 28, 2016.

Orange Book Transparency Act of 2019 : report (to accompany H.R. 1503) (including cost estimate of the Congressional Budget Office).
Published: (2019)

Why are some generic drugs skyrocketing in price? : hearing before the Subcommittee on Primary Health and Aging of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Thirteenth Congress, second session, on examining the pricing of generic drugs, November 20, 2014.
Published: (2017)

The effect of generic drug competition on generic drug prices during the Hatch-Waxman 180-day exclusivity period /
by: Olson, Luke M., et al.
Published: (2013)

Trends in brand name and generic prescribed medicine utilization and expenditures, 1999 to 2003 /
by: Stagnitti, Marie N.
Published: (2006)

Generic drug product development : solid oral dosage forms /
Published: (2005)

Frecuentes preguntas acerca de las drogas genéricas.
Published: (2004)

Sudden price spikes in decades-old prescription drugs : inside the monopoly business model : hearing before the Special Committee on Aging, United States Senate, One Hundred Fourteenth Congress, second session, Washington, DC, March 17, 2016.
Published: (2022)

Expanding the use of generic drugs.
Published: (2010)

Guidance for industry : alternate source of the active pharmaceutical ingredient in pending ANDAs.
Published: (2000)

Drug pricing : research on savings from generic drug use /
by: Dicken, John E.
Published: (2012)

Examining FDA's generic drug and biosimilar user fee programs : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Fifteenth Congress, first session, March 2, 2017.
Published: (2018)

How increased competition from generic drugs has affected prices and returns in the pharmaceutical industry.
Published: (1998)

How increased competition from generic drugs has affected prices and returns in the pharmaceutical industry.
Published: (1998)

Medicare Part D, prescription drug benefit : increasing use and access of affordable prescription drugs : a report of the Special Committee on Aging, United States Senate.
Published: (2014)

Generic drugs : saving money at the pharmacy.
Published: (1998)

Prescription drugs : price tends for frequently used brand and generic drugs from 2000 through 2004 : report to congressional requesters.
Published: (2005)

The marketing of generic drugs : a guide to counter-strategies for the technology intensive pharmaceutical companies /
by: James, Barrie G.
Published: (1981)

Authorized generic drugs : short-term effects and long-term impact.
Published: (2011)

Developments in the prescription drug market : oversight : hearing before the Committee on Oversight and Government Reform, House of Representatives, One Hundred Fourteenth Congress, second session, February 4, 2016.
Published: (2017)

Drug pricing : poor prescription for consumers and taxpayers? : hearing before the Committee on Governmental Affairs, United States Senate, One Hundred Third Congress, second session, July 27, 1994.
Published: (1995)

Increasing generic drug utilization : saving money for patients : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Ninth Congress, first session, May 18, 2005.
Published: (2005)

Increasing generic drug utilization : saving money for patients : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Ninth Congress, first session, May 18, 2005.
Published: (2005)

FDA's generic drug approval process : hearings before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred First Congress, first session.
Published: (1989)

Prescription drugs : implications of drug labeling and off-label use : statement of Sarah F. Jagger, Director of Health Services Quality and Public Health Issues, Health, Education, and Human Services Division, before the Subcommittee on Human Resources and Intergovernmental Relations, Committee on Government Reform and Oversight, U.S. House of Representatives /
by: Jagger, Sarah F.
Published: (1996)

Administered Prices. hearings before the United States Senate Committee on the Judiciary, Subcommittee on Antitrust and Monopoly, Eighty-Sixth Congress, second session, on May 10-13, 1960.
Published: (1960)

Entry threats and pricing in the generic drug industry /
by: Wendling, Brett
Published: (2010)

Frequently asked questions about prescription drug pricing and policy /
by: Kirchhoff, Suzanne M., et al.
Published: (2018)

FDA's generic drug application policy : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundredth Congress, second session, July 28, 1988.
Published: (1989)

Generic drugs : saving money at the pharmacy /
Published: (1998)

Generic pharmaceuticals : marketplace access and consumer issues : hearing before the Committee on Commerce, Science, and Transportation, United States Senate, One Hundred Seventh Congress, second session, April 23, 2002.
Published: (2004)

Generic pharmaceuticals : marketplace access and consumer issues : hearing before the Committee on Commerce, Science, and Transportation, United States Senate, One Hundred Seventh Congress, second session, April 23, 2002.
Published: (2004)

Skyrocketing prescription drug costs : effects on senior citizens : hearing before the Special Committee on Aging, United States Senate, One Hundred Second Congress, second session, Lewiston, ME, April 15, 1992.
Published: (1993)

Generic drug laws : a decade of trial, a prescription for progress /
Published: (1986)

Examining the root causes of drug shortages : challenges in pharmaceutical drug supply chains : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Eighteenth Congress, first session, May 11, 2023.
Published: (2024)

Facts about generic drugs.
Published: (2006)

Paying off generics to prevent competition with brand name drugs : should it be prohibited? : hearing before the Committee on the Judiciary, United States Senate, One Hundred Tenth Congress, first session, January 17, 2007.
Published: (2007)